200 related articles for article (PubMed ID: 10416371)
1. Identification of a novel HA conformational change inhibitor of human influenza virus.
Yoshimoto J; Kakui M; Iwasaki H; Fujiwara T; Sugimoto H; Hattori N
Arch Virol; 1999; 144(5):865-78. PubMed ID: 10416371
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of stachyflin on influenza A viruses of different hemagglutinin subtypes.
Motohashi Y; Igarashi M; Okamatsu M; Noshi T; Sakoda Y; Yamamoto N; Ito K; Yoshida R; Kida H
Virol J; 2013 Apr; 10():118. PubMed ID: 23587221
[TBL] [Abstract][Full Text] [Related]
3. Identification of amino acids of influenza virus HA responsible for resistance to a fusion inhibitor, Stachyflin.
Yoshimoto J; Kakui M; Iwasaki H; Sugimoto H; Fujiwara T; Hattori N
Microbiol Immunol; 2000; 44(8):677-85. PubMed ID: 11021398
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus.
Luo G; Torri A; Harte WE; Danetz S; Cianci C; Tiley L; Day S; Mullaney D; Yu KL; Ouellet C; Dextraze P; Meanwell N; Colonno R; Krystal M
J Virol; 1997 May; 71(5):4062-70. PubMed ID: 9094684
[TBL] [Abstract][Full Text] [Related]
5. Insights into structural and inhibitory mechanisms of low pH-induced conformational change of influenza HA2 protein: a computational approach.
Kannan S; Shankar R; Kolandaivel P
J Mol Model; 2019 Mar; 25(4):99. PubMed ID: 30904969
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
[TBL] [Abstract][Full Text] [Related]
7. Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity.
Hoffman LR; Kuntz ID; White JM
J Virol; 1997 Nov; 71(11):8808-20. PubMed ID: 9343241
[TBL] [Abstract][Full Text] [Related]
8. Stachyflin and acetylstachyflin, novel anti-influenza A virus substances, produced by Stachybotrys sp. RF-7260. II. Synthesis and preliminary structure-activity relationships of stachyflin derivatives.
Minagawa K; Kouzuki S; Kamigauchi T
J Antibiot (Tokyo); 2002 Feb; 55(2):165-71. PubMed ID: 12002998
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a hemagglutinin-specific inhibitor of influenza A virus.
Luo G; Colonno R; Krystal M
Virology; 1996 Dec; 226(1):66-76. PubMed ID: 8941323
[TBL] [Abstract][Full Text] [Related]
10. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.
Vanderlinden E; Göktas F; Cesur Z; Froeyen M; Reed ML; Russell CJ; Cesur N; Naesens L
J Virol; 2010 May; 84(9):4277-88. PubMed ID: 20181685
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin.
Plotch SJ; O'Hara B; Morin J; Palant O; LaRocque J; Bloom JD; Lang SA; DiGrandi MJ; Bradley M; Nilakantan R; Gluzman Y
J Virol; 1999 Jan; 73(1):140-51. PubMed ID: 9847316
[TBL] [Abstract][Full Text] [Related]
12. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.
Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J
Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin.
Zhu L; Li Y; Li S; Li H; Qiu Z; Lee C; Lu H; Lin X; Zhao R; Chen L; Wu JZ; Tang G; Yang W
PLoS One; 2011; 6(12):e29120. PubMed ID: 22195002
[TBL] [Abstract][Full Text] [Related]
14. Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment.
Puri A; Booy FP; Doms RW; White JM; Blumenthal R
J Virol; 1990 Aug; 64(8):3824-32. PubMed ID: 2196382
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546.
Basu A; Komazin-Meredith G; McCarthy C; Antanasijevic A; Cardinale SC; Mishra RK; Barnard DL; Caffrey M; Rong L; Bowlin TL
ACS Infect Dis; 2017 May; 3(5):330-335. PubMed ID: 28301927
[TBL] [Abstract][Full Text] [Related]
16. Development of anti-influenza virus drugs I: improvement of oral absorption and in vivo anti-influenza activity of Stachyflin and its derivatives.
Yagi S; Ono J; Yoshimoto J; Sugita K; Hattori N; Fujioka T; Fujiwara T; Sugimoto H; Hirano K; Hashimoto N
Pharm Res; 1999 Jul; 16(7):1041-6. PubMed ID: 10450928
[TBL] [Abstract][Full Text] [Related]
17. Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series.
Brancato V; Peduto A; Wharton S; Martin S; More V; Di Mola A; Massa A; Perfetto B; Donnarumma G; Schiraldi C; Tufano MA; de Rosa M; Filosa R; Hay A
Antiviral Res; 2013 Aug; 99(2):125-35. PubMed ID: 23707194
[TBL] [Abstract][Full Text] [Related]
18. Action of rimantadine on the structure of influenza A virus haemagglutinin.
Mikheeva AV; Melnikov AYa ; Anisimova E
Acta Virol; 1989 Mar; 33(2):131-6. PubMed ID: 2569808
[TBL] [Abstract][Full Text] [Related]
19. Exploring the early stages of the pH-induced conformational change of influenza hemagglutinin.
Zhou Y; Wu C; Zhao L; Huang N
Proteins; 2014 Oct; 82(10):2412-28. PubMed ID: 24854389
[TBL] [Abstract][Full Text] [Related]
20. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
